Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-06-14
2011-06-14
Bunner, Bridget E (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S350000, C530S388100, C530S388260
Reexamination Certificate
active
07960513
ABSTRACT:
Elucidation of the crystal structure of an ADAM10 substrate-recognition and proteinase-positioning module comprising the protein cysteine-rich and disintegrin domains, and detailed functional analysis revealed that an acidic pocket within the cysteine-rich domain forms a substrate-recognition site. The binding of this pocket to receptor/ligand complexes facilitates effective ligand cleavage, which is prevented when critical residues within the pocket are changed. This provides use of the surface pocket within the extracellular domain of ADAM10, and the corresponding structure in related proteases such as ADAM17, as a target for structure-based computational and high-throughput screens for small-molecule substrate-specific inhibitors or monoclonal antibodies that inhibit ADAM protease cleavage of ephrins and other ADAM10 or ADAM17 substrates. These inhibitors will be useful in therapeutic intervention of tumour development, invasion and metastasis and other diseases which involve the activity of the ADAM10 and ADAM17 proteases, such as inflammation, cardio-vascular disease, arthritis and other auto-immune diseases.
REFERENCES:
Zou et al, Catalytic activity of human ADAM33. J Biol Chem. Mar. 12, 2004;279(11):9818-30. Epub Dec. 15, 2003.
Skolnick et al. From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends in Biotech 18(1): 34-39, 2000.
Bork, A. Powers and pitfalls in sequence analysis: the 70% hurdle. Genome Res 10: 398-400, 2000.
Doerks et al. Protein annotation: detective work for function prediction. Trends in Genetics 14(6): 248-250, 1998.
Smith et al. The challenges of genome sequence annotation or “The devil is in the details”. Nature Biotech 15: 1222-1223, 1997.
Brenner, S.E. Errors in genome function. Trends in Genetics 15(4): 132-133, 1999.
Bork et al. Go hunting in sequence databases but watch out for the traps. Trends in Genetics. 12(10): 425-427, 1996.
Ngo et al. Computational complexity, protein structure prediction, and the Levinthal paradox. The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495, 1994.
Lederman et al. A single amino acid substitution in a common African allele of the CD4 molecule ablates binding of the monoclonal antibody, OKT4. Mol Immunol. 28(11):1171-1181, 1991.
Li et al. beta-Endorphin omission analogs: dissociation of immunoreactivity from other biological activities.Proc Natl Acad Sci U S A. 77(6):3211-3214, 1980.
Rosendahl et al. Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases. J Biol Chem 272(39): 24588-24593, 1997.
Daniel et al. Virology 202: 540-549, 1994.
R&D Systems technical datasheet for Mab1427; internet release Jun. 2, 2003 and print release Jun. 1, 2003; 2 pages.
R&D Systems technical datasheet for Ab936; internet release Apr. 14, 2003 and Jun. 1, 2003; 2 pages.
R&D Systems 2004 Catalog listing for Mab1427 and Ab936; title page and p. 323.
Frayne et al.,Molecular Human Reproduction, 8(9): 817-822 (2002).
Huang et al.,Development, 130(14): 3147-3161 (2003).
Janes et al.,Cell, 123(2): 291-304 (Oct. 21, 2005).
Loechel et al.,FEBS Letters, 506: 65-68 (Sep. 2001).
Reddy et al.,Journal of Biological Chemistry, 275(19): 14608-14614 (May 12, 2000).
Smith et al.,Journal of Cell Biology, 159(5): 893-902 (Dec. 9, 2002).
Janes Peter W.
Lackmann Martin
Nikolov Dimitar B.
Saha Nayanendu
Bunner Bridget E
Leydig , Voit & Mayer, Ltd.
Memorial Sloan Kettering Cancer Center
Monash University
LandOfFree
Antibody against a human ADAM protease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody against a human ADAM protease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody against a human ADAM protease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2629553